Zobrazeno 1 - 10
of 160
pro vyhledávání: '"anti-dementia drugs"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ilaria Ippoliti, Antonio Ancidoni, Roberto Da Cas, Andrea Pierantozzi, Nicola Vanacore, Francesco Trotta
Publikováno v:
Neurological Sciences. 44:1587-1595
Introduction Acetylcholinesterase inhibitors (AChEIs) and memantine are currently the only anti-dementia drugs (ADDs) approved for treating Alzheimer’s disease (AD) in Italy. This nationwide study aims to characterize dementia drug utilization in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b833534e6fe71aed7fc0a7bf1e12d56
https://doi.org/10.1007/s10072-022-06586-8
https://doi.org/10.1007/s10072-022-06586-8
Autor:
Ramón Cacabelos, Vinogran Naidoo, Olaia Martínez-Iglesias, Lola Corzo, Natalia Cacabelos, Rocío Pego, Juan C. Carril
Publikováno v:
Life, Vol 12, Iss 3, p 460 (2022)
Alzheimer’s disease (AD) is a priority health problem with a high cost to society and a large consumption of medical and social resources. The management of AD patients is complex and multidisciplinary. Over 90% of patients suffer from concomitant
Externí odkaz:
https://doaj.org/article/4857e8b2184348ddb68d2a0e563cf036
Autor:
V. A. Parfenov, S. V. Verbitskaya
Publikováno v:
Медицинский совет, Vol 0, Iss 18, Pp 10-15 (2018)
Cognitive impairment (CI) is one of the causes of acquired disability in post-stroke patients. The article presents an analysis of the prevalence, pathogenesis, manifestations, diagnosis, treatment and prevention of post-stroke CI. It is noted that C
Externí odkaz:
https://doaj.org/article/501e9c458a0f4190bb39b3d1a8f35749
Autor:
Carlo Tomino, Sara Ilari, Vincenzo Solfrizzi, Valentina Malafoglia, Guglielmo Zilio, Patrizia Russo, Stefania Proietti, Federica Marcolongo, Giovanni Scapagnini, Carolina Muscoli, Paolo Maria Rossini
Publikováno v:
Pharmaceuticals, Vol 14, Iss 4, p 305 (2021)
Mild cognitive impairment (MCI) and dementia are clinically prevalent in the elderly. There is a high risk of cognitive decline in patients diagnosed with MCI or dementia. This review describes the effectiveness of Ginkgo biloba leaf special extract
Externí odkaz:
https://doaj.org/article/a9c122d4a9f647e484096debbfbeabfa
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Masafumi Kuzuya, Mikio Sakakibara, Hitoshi Komiya, Nariaki Shiraishi, Masahiro Akishita, Yusuke Suzuki
Publikováno v:
Dement Geriatr Cogn Disord
Aims: As the number of older people with dementia increases, safe pharmacotherapy in this population has attracted attention in recent years. The aims of this study were to clarify the prescribing patterns in older patients who were prescribed anti-d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75512ddea5e3ece5f35f367881cdcb2c
https://doi.org/10.1159/000512043
https://doi.org/10.1159/000512043
Autor:
Sara Ilari, Patrizia Russo, Guglielmo Zilio, Federica Marcolongo, Valentina Malafoglia, Carlo Tomino, Vincenzo Solfrizzi, Carolina Muscoli, Paolo Maria Rossini, Giovanni Scapagnini
Mild cognitive impairment (MCI) and mild dementia are a clinically relevant health problem in the elderly and Alzheimer's disease being the most common neurodegenerative disorder. Furthermore, MCI and mild dementia are characterized by a deterioratio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a084da13f0a68f50d29bd0b754c48467
Autor:
Vincenzo Solfrizzi, Carolina Muscoli, Guglielmo Zilio, Paolo Maria Rossini, Sara Ilari, Stefania Proietti, Valentina Malafoglia, Patrizia Russo, Federica Marcolongo, Carlo Tomino, Giovanni Scapagnini
Publikováno v:
Pharmaceuticals, Vol 14, Iss 305, p 305 (2021)
Pharmaceuticals
Pharmaceuticals
Mild cognitive impairment (MCI) and dementia are clinically prevalent in the elderly. There is a high risk of cognitive decline in patients diagnosed with MCI or dementia. This review describes the effectiveness of Ginkgo biloba leaf special extract
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55a8dfd3078353c0077a80147204cb1f
http://hdl.handle.net/11695/99300
http://hdl.handle.net/11695/99300
Autor:
Ramón Cacabelos
Publikováno v:
Expert Review of Precision Medicine and Drug Development. 3:163-188
Introduction: There is an alarming lack of therapeutic options for dementia (Alzheimer’s disease, vascular/mixed dementia). Despite the enormous effort made by scientists, industry and society, no ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e8d8f1e9613a6adbe82d1e2cdb96370
https://doi.org/10.1080/23808993.2018.1468218
https://doi.org/10.1080/23808993.2018.1468218